329 related articles for article (PubMed ID: 32384189)
21. Discovery of metabolomic biomarkers for discriminating platinum-sensitive and platinum-resistant ovarian cancer by using GC-MS.
Eroglu EC; Tunug S; Geckil OF; Gulec UK; Vardar MA; Paydas S
Eur J Mass Spectrom (Chichester); 2021 Dec; 27(6):235-248. PubMed ID: 34806450
[TBL] [Abstract][Full Text] [Related]
22. Lipid metabolism and oxidative stress in patients with Alzheimer's disease and amnestic mild cognitive impairment.
Nie Y; Chu C; Qin Q; Shen H; Wen L; Tang Y; Qu M
Brain Pathol; 2024 Jan; 34(1):e13202. PubMed ID: 37619589
[TBL] [Abstract][Full Text] [Related]
23. Serum Metabolic Profiling Reveals Altered Metabolic Pathways in Patients with Post-traumatic Cognitive Impairments.
Yi L; Shi S; Wang Y; Huang W; Xia ZA; Xing Z; Peng W; Wang Z
Sci Rep; 2016 Feb; 6():21320. PubMed ID: 26883691
[TBL] [Abstract][Full Text] [Related]
24. Metabolic profiling of Alzheimer's disease: Untargeted metabolomics analysis of plasma samples.
Milos T; Rojo D; Nedic Erjavec G; Konjevod M; Tudor L; Vuic B; Svob Strac D; Uzun S; Mimica N; Kozumplik O; Barbas C; Zarkovic N; Pivac N; Nikolac Perkovic M
Prog Neuropsychopharmacol Biol Psychiatry; 2023 Dec; 127():110830. PubMed ID: 37454721
[TBL] [Abstract][Full Text] [Related]
25. Potential metabolomic biomarkers for reliable diagnosis of Behcet's disease using gas chromatography/ time-of-flight-mass spectrometry.
Ahn JK; Kim J; Hwang J; Song J; Kim KH; Cha HS
Joint Bone Spine; 2018 May; 85(3):337-343. PubMed ID: 28549946
[TBL] [Abstract][Full Text] [Related]
26. Amnestic mild cognitive impairment and conversion to Alzheimer's disease: insulin resistance and glycoxidation as early biomarker clusters.
Monacelli F; Borghi R; Cammarata S; Nencioni A; Piccini A; Tabaton M; Odetti P
J Alzheimers Dis; 2015; 45(1):89-95. PubMed ID: 25471189
[TBL] [Abstract][Full Text] [Related]
27. UHPLC-QTOF/MS-based metabolomics investigation for the protective mechanism of Danshen in Alzheimer's disease cell model induced by Aβ
Zhang M; Liu Y; Liu M; Liu B; Li N; Dong X; Hong Z; Chai Y
Metabolomics; 2019 Jan; 15(2):13. PubMed ID: 30830431
[TBL] [Abstract][Full Text] [Related]
28. Urinary metabolomic study of systemic lupus erythematosus based on gas chromatography/mass spectrometry.
Yan B; Huang J; Dong F; Yang L; Huang C; Gao M; Shi A; Zha W; Shi L; Hu X
Biomed Chromatogr; 2016 Nov; 30(11):1877-1881. PubMed ID: 27061577
[TBL] [Abstract][Full Text] [Related]
29. Increased Serum miR-206 Level Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Follow-up Study.
Xie B; Liu Z; Jiang L; Liu W; Song M; Zhang Q; Zhang R; Cui D; Wang X; Xu S
J Alzheimers Dis; 2017; 55(2):509-520. PubMed ID: 27662297
[TBL] [Abstract][Full Text] [Related]
30. Serum and urine metabolomics based on UPLC-QTOF/MS reveal the effect and potential mechanism of "schisandra-evodia" herb pair in the treatment of Alzheimer's disease.
Pang C; Wang R; Liu K; Yuan X; Ni J; Cao Q; Chen Y; Dong PL; Han H
Biomed Chromatogr; 2024 Jul; 38(7):e5882. PubMed ID: 38649307
[TBL] [Abstract][Full Text] [Related]
31. Integrated network pharmacology analysis and serum metabolomics to reveal the cognitive improvement effect of Bushen Tiansui formula on Alzheimer's disease.
Zhang Z; Yi P; Yang J; Huang J; Xu P; Hu M; Zhang C; Wang B; Peng W
J Ethnopharmacol; 2020 Mar; 249():112371. PubMed ID: 31683034
[TBL] [Abstract][Full Text] [Related]
32. GC-TOF/MS-based metabolomics approach to study the cellular immunotoxicity of deoxynivalenol on murine macrophage ANA-1 cells.
Ji J; Sun J; Pi F; Zhang S; Sun C; Wang X; Zhang Y; Sun X
Chem Biol Interact; 2016 Aug; 256():94-101. PubMed ID: 27350164
[TBL] [Abstract][Full Text] [Related]
33. Plasma metabolic profiling of mild cognitive impairment and Alzheimer's disease using liquid chromatography/mass spectrometry.
Liu Y; Li N; Zhou L; Li Q; Li W
Cent Nerv Syst Agents Med Chem; 2014; 14(2):113-20. PubMed ID: 25515716
[TBL] [Abstract][Full Text] [Related]
34. Untargeted Metabolomic Profiling Reveals Differentially Expressed Serum Metabolites and Pathways in Type 2 Diabetes Patients with and without Cognitive Decline: A Cross-Sectional Study.
Al-Akl NS; Khalifa O; Ponirakis G; Parray A; Ramadan M; Khan S; Chandran M; Ayadathil R; Elsotouhy A; Own A; Al Hamad H; Decock J; Alajez NM; Albagha O; Malik RA; El-Agnaf OMA; Arredouani A
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396924
[TBL] [Abstract][Full Text] [Related]
35. Metabolomics and Cytokine Analysis for Identification of Severe Drug-Induced Liver Injury.
Xie Z; Chen E; Ouyang X; Xu X; Ma S; Ji F; Wu D; Zhang S; Zhao Y; Li L
J Proteome Res; 2019 Jun; 18(6):2514-2524. PubMed ID: 31002254
[TBL] [Abstract][Full Text] [Related]
36. Salivaomics as a Potential Tool for Predicting Alzheimer's Disease During the Early Stages of Neurodegeneration.
François M; Karpe A; Liu JW; Beale D; Hor M; Hecker J; Faunt J; Maddison J; Johns S; Doecke J; Rose S; Leifert WR
J Alzheimers Dis; 2021; 82(3):1301-1313. PubMed ID: 34151801
[TBL] [Abstract][Full Text] [Related]
37. Metabolic Profiling of Neocortical Tissue Discriminates Alzheimer's Disease from Mild Cognitive Impairment, High Pathology Controls, and Normal Controls.
Jasbi P; Shi X; Chu P; Elliott N; Hudson H; Jones D; Serrano G; Chow B; Beach TG; Liu L; Jentarra G; Gu H
J Proteome Res; 2021 Sep; 20(9):4303-4317. PubMed ID: 34355917
[TBL] [Abstract][Full Text] [Related]
38. Untargeted metabolomic profiling of accessory sex gland fluid from Morada Nova rams.
Sousa SD; Lucini L; Ajmone-Marsan P; van Tilburg MF; Moura AA
Mol Reprod Dev; 2020 Apr; 87(4):409-418. PubMed ID: 32202367
[TBL] [Abstract][Full Text] [Related]
39. GC-MS-based metabolomics reveals mechanism of action for hydrazine induced hepatotoxicity in rats.
Bando K; Kunimatsu T; Sakai J; Kimura J; Funabashi H; Seki T; Bamba T; Fukusaki E
J Appl Toxicol; 2011 Aug; 31(6):524-35. PubMed ID: 21154879
[TBL] [Abstract][Full Text] [Related]
40. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
